Repurposed drug enters clinical trial for Lewy body dementia
Researchers in the US have launched a clinical trial to test a drug with the potential to slow the progression of Lewy body dementia.
Test to detect early Parkinson's given FDA Breakthrough Device Designation
The biotech company Amprion have developed a test to detect the early signs of Parkinson's, before the onset of symptoms, which they hope will be ready to market in the next 18 months.
Shaping the volunteer awards
Our values shape the new volunteer awards, so we take a look at some of the volunteers showcasing them.
New study suggests that having bipolar disorder increases the risk of Parkinson's
People with bipolar disorder are almost 7 times more likely to develop Parkinson's than those without the condition, according to new research published in the journal Neurology.
Progress on our mental health campaigning
A brief update on the progress of our mental health campaigning
A warm welcome at the Belfast early onset Parkinson's cafe
Parkinson's UK Northern Ireland launched its early onset Parkinson's cafe, Belfast in June 2017. We catch up on how it's going.
Meeting with the Minister for Disabled People
A report on a recent meeting with the new Minister for Disabled People, Health and Work.
Pension Credit changes will take money away from those who need it most
Pension Credit changes and what it could mean for people with Parkinson's and their carers.
New insights into the link between the appendix and Parkinson's
The media reports on a large-scale study that suggests the removal of the appendix may increase the risk of Parkinson's.
Phase II trial is underway investigating a gene therapy for Parkinson's
Axovant Gene Therapies Ltd., a company developing innovative gene therapies, has announced they are entering the next stage of a phase II gene therapy trial for Parkinson's.